BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 25528332)

  • 1. Design and synthesis of new 2-arylnaphthyridin-4-ones as potent antitumor agents targeting tumorigenic cell lines.
    Liu CY; Cheng YY; Chang LC; Huang LJ; Chou LC; Huang CH; Tsai MT; Liao CC; Hsu MH; Lin HY; Wu TS; Wen YF; Zhao Y; Kuo SC; Lee KH
    Eur J Med Chem; 2015 Jan; 90():775-87. PubMed ID: 25528332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis, in vitro and in vivo evaluation of novel substituted N-(4-(2-(4-benzylpiperazin-1-yl)ethoxy)phenyl)-N-methyl-quinazolin-4-amines as potent antitumor agents.
    Cao D; Wang X; Lei L; Ma L; Wang F; Wang C; Tang M; Xiang W; Wang T; Li H; Chen L
    Bioorg Med Chem Lett; 2016 Apr; 26(8):1931-5. PubMed ID: 26979159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microwave-assisted synthesis of pyrimido[4,5-b][1,6]naphthyridin-4(3H)-ones with potential antitumor activity.
    Insuasty B; Becerra D; Quiroga J; Abonia R; Nogueras M; Cobo J
    Eur J Med Chem; 2013 Feb; 60():1-9. PubMed ID: 23279862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, synthesis and biological evaluation of novel thioquinazolinone-based 2-aminobenzamide derivatives as potent histone deacetylase (HDAC) inhibitors.
    Cheng C; Yun F; He J; Ullah S; Yuan Q
    Eur J Med Chem; 2019 Jul; 173():185-202. PubMed ID: 31003060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Straightforward synthesis and biological evaluation as topoisomerase I inhibitors and antiproliferative agents of hybrid Chromeno[4,3-b][1,5]Naphthyridines and Chromeno[4,3-b][1,5]Naphthyridin-6-ones.
    Martín-Encinas E; Rubiales G; Knudssen BR; Palacios F; Alonso C
    Eur J Med Chem; 2019 Sep; 178():752-766. PubMed ID: 31229877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, synthesis, and evaluations of the antiproliferative activity and aqueous solubility of novel carbazole sulfonamide derivatives as antitumor agents.
    Sun L; Wang C; Hu X; Wu Y; Jiang Z; Li Z; Chen X; Hu L
    Bioorg Chem; 2020 Jun; 99():103766. PubMed ID: 32247110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and antiproliferative activity of pyrrolo[2,3-b]pyridine derivatives bearing the 1,8-naphthyridin-2-one moiety.
    Tang Q; Duan Y; Wang L; Wang M; Ouyang Y; Wang C; Mei H; Tang S; Xiong Y; Zheng P; Gong P; Zhu W
    Eur J Med Chem; 2018 Jan; 143():266-275. PubMed ID: 29197731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of 13H-benzo[f]chromeno[4,3-b][1,7]naphthyridines and their salts as potent cytotoxic agents and topoisomerase I/IIα inhibitors.
    Arepalli SK; Lee C; Sim S; Lee K; Jo H; Jun KY; Kwon Y; Kang JS; Jung JK; Lee H
    Bioorg Med Chem; 2018 Oct; 26(18):5181-5193. PubMed ID: 30253887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, synthesis, and preclinical evaluation of new 5,6- (or 6,7-) disubstituted-2-(fluorophenyl)quinolin-4-one derivatives as potent antitumor agents.
    Chou LC; Tsai MT; Hsu MH; Wang SH; Way TD; Huang CH; Lin HY; Qian K; Dong Y; Lee KH; Huang LJ; Kuo SC
    J Med Chem; 2010 Nov; 53(22):8047-58. PubMed ID: 20973552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis and biological evaluation of a series of pyrano chalcone derivatives containing indole moiety as novel anti-tubulin agents.
    Wang G; Li C; He L; Lei K; Wang F; Pu Y; Yang Z; Cao D; Ma L; Chen J; Sang Y; Liang X; Xiang M; Peng A; Wei Y; Chen L
    Bioorg Med Chem; 2014 Apr; 22(7):2060-79. PubMed ID: 24629450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, synthesis, biological evaluation and structure-activity relationship of sophoridine derivatives bearing pyrrole or indole scaffold as potential antitumor agents.
    Li Z; Luo M; Cai B; Haroon-Ur-Rashid ; Huang M; Jiang J; Wang L; Wu L
    Eur J Med Chem; 2018 Sep; 157():665-682. PubMed ID: 30125725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and antiproliferative activity of 6,7-disubstituted-4-phenoxyquinoline derivatives bearing the 1,8-naphthyridin-2-one moiety.
    Tang Q; Duan Y; Xiong H; Chen T; Xiao Z; Wang L; Xiao Y; Huang S; Xiong Y; Zhu W; Gong P; Zheng P
    Eur J Med Chem; 2018 Oct; 158():201-213. PubMed ID: 30216852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, synthesis and pharmacological evaluation of new 3-(1H-benzimidazol-2-yl)quinolin-2(1H)-one derivatives as potential antitumor agents.
    Kuang WB; Huang RZ; Qin JL; Lu X; Qin QP; Zou BQ; Chen ZF; Liang H; Zhang Y
    Eur J Med Chem; 2018 Sep; 157():139-150. PubMed ID: 30092368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, synthesis and bioactivity study of evodiamine derivatives as multifunctional agents for the treatment of hepatocellular carcinoma.
    Fan X; Deng J; Shi T; Wen H; Li J; Liang Z; Lei F; Liu D; Zhang H; Liang Y; Hao X; Wang Z
    Bioorg Chem; 2021 Sep; 114():105154. PubMed ID: 34378540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antitumor agents. 174. 2',3',4',5,6,7-Substituted 2-phenyl-1,8-naphthyridin-4-ones: their synthesis, cytotoxicity, and inhibition of tubulin polymerization.
    Chen K; Kuo SC; Hsieh MC; Mauger A; Lin CM; Hamel E; Lee KH
    J Med Chem; 1997 Jul; 40(14):2266-75. PubMed ID: 9216846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, synthesis and biological evaluation of 3-nitro-1,8-naphthalimides as potential antitumor agents.
    Xin M; Wei JH; Yang CH; Liang GB; Su D; Ma XL; Zhang Y
    Bioorg Med Chem Lett; 2020 Apr; 30(8):127051. PubMed ID: 32111436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of novel bis-pyrazole derivatives as antitumor agents with potent apoptosis induction effects and DNA damage.
    Dai H; Ge S; Guo J; Chen S; Huang M; Yang J; Sun S; Ling Y; Shi Y
    Eur J Med Chem; 2018 Jan; 143():1066-1076. PubMed ID: 29232583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, synthesis, in vitro antiproliferative activity and apoptosis-inducing studies of 1-(3',4',5'-trimethoxyphenyl)-3-(2'-alkoxycarbonylindolyl)-2-propen-1-one derivatives obtained by a molecular hybridisation approach.
    Preti D; Romagnoli R; Rondanin R; Cacciari B; Hamel E; Balzarini J; Liekens S; Schols D; Estévez-Sarmiento F; Quintana J; Estévez F
    J Enzyme Inhib Med Chem; 2018 Dec; 33(1):1225-1238. PubMed ID: 30141353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and biological evaluation of indeno[1,5]naphthyridines as topoisomerase I (TopI) inhibitors with antiproliferative activity.
    Alonso C; Fuertes M; González M; Rubiales G; Tesauro C; Knudsen BR; Palacios F
    Eur J Med Chem; 2016 Jun; 115():179-90. PubMed ID: 27017547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis, antitumor activity, and mechanism of action of benzo[b]chromeno[6,5-g][1,8]naphthyridin-7-one analogs of acronycine.
    Tian W; Yougnia R; Depauw S; Lansiaux A; David-Cordonnier MH; Pfeiffer B; Kraus-Berthier L; Léonce S; Pierré A; Dufat H; Michel S
    J Med Chem; 2014 Dec; 57(24):10329-42. PubMed ID: 25360689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.